|
| Home : XTANDI® (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis |
|
May 29
2020 |
XTANDI® (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis |
|
TOKYO, May 29, 2020 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has approved XTANDI® (enzalutamide), an oral androgen receptor signaling inhibitor, for... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/xtandi-enzalutamide-approved-by-japan-mhlw-for-the-treatment-of-prostate-cancer-with-distant-metastasis-301067417.html |
| |
|
Related News
|
» Autoliv Provides Market and Business Update, Accelerates Mitigating Measures and Enters Loan Facility With Swedish Export Credit Corporation
» WATCH: Coronavirus daily update: May 28, 2020
|
|
|
